サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1769587

製薬・バイオテクノロジーCRMソフトウェアの世界市場：2034年までのビジネスチャンスと戦略

Pharma And Biotech CRM Software Global Market Opportunities And Strategies To 2034

出版日
ページ情報
英文 330 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
製薬・バイオテクノロジーCRMソフトウェアの世界市場：2034年までのビジネスチャンスと戦略
出版日: 2025年07月09日
発行: The Business Research Company
ページ情報: 英文 330 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の製薬・バイオテクノロジーCRMソフトウェア市場は2019年に27億9,965万米ドルと評価され、2024年までCAGR9.00%以上で成長しました。

遠隔医療と遠隔ヘルスケアの拡大

過去中、遠隔医療とリモートヘルスケアの拡大が製薬・バイオテクノロジーCRMソフトウェア市場の成長を支えました。遠隔医療は、医療提供者、患者、製薬会社の間に新たなデジタル接点を生み出し、コミュニケーション、配合、フォローアップの効率的な管理を要求しています。製薬会社のCRMシステムは、患者データの収集と分析を支援し、パーソナライズされたマーケティングを可能にし、患者エンゲージメントを高めます。また、仮想プラットフォーム、電話、電子メールを介したシームレスなマルチチャネルコミュニケーションをサポートし、遠隔医療の多様なインタラクションに不可欠です。移動の制約により直接のミーティングが制限される中、CRMツールは、バーチャルなディテーリングやウェビナーを通じて、遠隔地からのセールスやマーケティングを促進し、効果的なステークホルダー・エンゲージメントを維持します。例えば、2023年8月、米国を拠点とするヘルスケア技術企業であるVivalinkによると、最近の調査では、臨床医の81％が遠隔患者モニタリング（RPM）を使用しており、2021年の20％から305％増加しています。さらに、現在のRPMユーザーの84％が2024年にその使用を拡大する予定です。さらに、米国の非営利団体FAIR Health Inc.によれば、2023年4月、全米の遠隔医療利用は7.3%増加し、2022年12月の医療請求行の5.5%から2023年1月には5.9%になりました。したがって、遠隔医療と遠隔ヘルスケアの拡大が製薬・バイオテクノロジーCRMソフトウェア市場の成長を牽引しました。

目次

第1章 エグゼクティブサマリー

  • 製薬・バイオテクノロジーCRMソフトウェア-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • 製薬・バイオテクノロジーCRMソフトウェア市場定義とセグメンテーション
  • 市場セグメンテーション：技術別
    • 人工知能による顧客関係管理（CRM）
    • 従来型顧客関係管理（CRM）
  • 市場セグメンテーション：展開別
    • オンプレミス
    • クラウドベース
  • 市場セグメンテーション：企業規模別
    • 大企業
    • 中小企業
  • 市場セグメンテーション：産業別
    • 医薬品
    • バイオテクノロジー

第7章 主要な市場動向

  • 電子健康記録を製薬CRMシステムに統合
  • 戦略的パートナーシップが製薬・バイオテクノロジーCRMソフトウェアのイノベーションを推進
  • 音声制御CRMインターフェースが医薬品販売の生産性を向上

第8章 世界の製薬・バイオテクノロジーCRMソフトウェアの成長分析と戦略分析フレームワーク

  • 世界：PESTEL分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • B2B市場のエンドユーザー
    • 製薬会社
    • バイオテクノロジー企業
  • 世界の市場規模と成長
  • 市場成長実績、2019～2024年
    • 市場促進要因、2019～2024年
    • 市場抑制要因、2019～2024年
  • 市場成長予測、2024～2029年、2034年
  • 成長予測の貢献要因
    • 量的成長の貢献要因
    • 促進要因
    • 抑制要因
  • 世界の製薬・バイオテクノロジーCRMソフトウェア：総潜在市場規模（TAM）

第9章 世界の製薬・バイオテクノロジーCRMソフトウェア市場：セグメンテーション

  • 世界の製薬・バイオテクノロジーCRMソフトウェア市場：技術別、実績と予測、2019～2024年、2029年、2034年
  • 世界の製薬・バイオテクノロジーCRMソフトウェア市場：展開別、実績と予測、2019～2024年、2029年、2034年
  • 世界の製薬・バイオテクノロジーCRMソフトウェア市場：企業規模別、実績と予測、2019～2024年、2029年、2034年
  • 世界の製薬・バイオテクノロジーCRMソフトウェア市場：産業別、実績と予測、2019～2024年、2029年、2034年
  • 世界の製薬・バイオテクノロジーCRMソフトウェア市場、人工知能による顧客関係管理（CRM）のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 世界の製薬・バイオテクノロジーCRMソフトウェア市場、従来型顧客関係管理（CRM）のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年

第10章 製薬・バイオテクノロジーCRMソフトウェア市場：地域・国別分析

  • 世界の製薬・バイオテクノロジーCRMソフトウェア市場：地域別、実績と予測、2019～2024年、2029年、2034年
  • 世界の製薬・バイオテクノロジーCRMソフトウェア市場：国別、実績と予測、2019～2024年、2029年、2034年

第11章 アジア太平洋市場

第12章 西欧市場

第13章 東欧市場

第14章 北米市場

第15章 南米市場

第16章 中東市場

第17章 アフリカ市場

第18章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Veeva Systems Inc
  • IQVIA Holdings Inc
  • Salesforce Inc
  • Oracle Corporation
  • SAP SE

第19章 その他の大手企業と革新的企業

  • Microsoft Corporation
  • Zoho Corporation Pvt. Ltd.
  • Pega Systems Inc.
  • HubSpot Inc.
  • Indegene Private Limited
  • Aurea Software Inc.
  • Axtria Inc.
  • Pipedrive Inc.
  • Syneos Health Inc.
  • Close-Up International Limited
  • CRMNEXT Pharmaceutical
  • SugarCRM Inc.
  • Creatio（旧bpm'online）
  • StayinFront Inc.
  • Synergistix Inc.

第20章 競合ベンチマーキング

第21章 競合ダッシュボード

第22章 主要な合併と買収

  • ValsoftがExeevoを買収
  • Zensar TechnologiesがBridgeView Life Sciencesを買収
  • NomadiaがNomadvantageを買収
  • AktanaがTact.aiを買収

第23章 最近の動向：製薬・バイオテクノロジーCRMソフトウェア市場

第24章 機会と戦略

  • 世界の製薬・バイオテクノロジーCRMソフトウェア市場、2029年：新たな機会を提供する国
  • 世界の製薬・バイオテクノロジーCRMソフトウェア市場、2029年：新たな機会を提供するセグメント
  • 世界の製薬・バイオテクノロジーCRMソフトウェア市場、2029年：成長戦略
    • 市場動向による戦略
    • 競合の戦略

第25章 製薬・バイオテクノロジーCRMソフトウェア市場：結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人材

第26章 付録

目次
Product Code: o&s1711

The pharma and biotech customer relationship management (CRM) software market refers to the specialized segment of CRM systems designed to address the unique needs of pharmaceutical and biotechnology companies. This software supports organizations in managing relationships with healthcare professionals, hospitals, distributors, research institutions, and regulatory bodies.

The pharma and biotech CRM software market consists of sales, by entities (organizations, sole traders, or partnerships), of customer relationship management solutions specifically designed for the pharmaceutical and biotech industries. These solutions enable companies to manage and analyze customer interactions, streamline sales and marketing activities, and maintain compliance with industry regulations.

The global pharma and biotech CRM software market was valued at $2,799.65 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 9.00%.

Expansion Of Telemedicine And Remote Healthcare

During the historic period, the expansion of telemedicine and remote healthcare supported the growth of the pharma and biotech CRM software market. Telemedicine has created new digital touchpoints between healthcare providers, patients, and pharmaceutical companies, requiring efficient management of communications, prescriptions, and follow-ups. Pharma CRM systems help collect and analyze patient data to enable personalized marketing and enhance patient engagement. They also support seamless multi-channel communication across virtual platforms, phone, and email, crucial for telemedicine's diverse interactions. With travel restrictions limiting in-person meetings, CRM tools facilitate remote sales and marketing through virtual detailing and webinars, maintaining effective stakeholder engagement. For instance, in August 2023, according to the Vivalink, a US-based healthcare technology company, a recent survey found that 81% of clinicians use remote patient monitoring (RPM), up from 20% in 2021, marking a 305% increase. Additionally, 84% of current RPM users plan to expand its use in 2024. Additionally, in April 2023, according to FAIR Health Inc., a US-based non-profit organization, National telehealth use increased by 7.3%, from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Therefore, the expansion of telemedicine and remote healthcare drove the growth of the pharma and biotech CRM software market.

Integrating Electronic Health Records Into Pharma CRM Systems

Major companies operating in the pharma and biotech CRM software market are increasingly integrating artificial intelligence (AI) and machine learning into their platforms to meet the rising demand for advanced, industry-specific customer engagement tools. AI-powered personalized engagement allows companies to deliver highly targeted and relevant communications to healthcare professionals (HCPs), patients, and other key stakeholders. For example, in October 2023, Salesforce Inc, a US-based cloud software provider, introduced its new Life Sciences Cloud, a secure platform for pharmaceutical (pharma) and medical technology (medtech) organizations. This platform leverages data, automation, and trusted AI to enhance patient engagement, streamline clinical operations, and manage the commercial lifecycle. It supports organizations in delivering personalized stakeholder experiences throughout the drug and device development process. The Life Sciences Cloud integrates data from multiple sources, including electronic health records and clinical trial systems, to provide a unified view of patients and providers. It also offers compliance tools tailored to the regulatory requirements of the healthcare industry.

The global pharma and biotech CRM software market is highly concentrated, with large players operating in the market. The top ten competitors in the market made up to 94.96% of the total market in 2023.

Pharma And Biotech CRM Software Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global pharma and biotech CRM software market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for pharma and biotech CRM software? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The pharma and biotech CRM software market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider pharma and biotech CRM software market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by technology, by deployment, by enterprise size and by industry.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Global Market Size And Growth- Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by technology, by deployment, by enterprise size and by industry in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Recent Developments- Information on recent developments in the market covered in the report.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for pharma and biotech CRM software providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Technology: Artificial Intelligence Customer Relationship Management (CRM); Conventional Customer Relationship Management (CRM)
  • 2) By Deployment: On-Premise; Cloud-Based
  • 3) By Enterprise Size: Large Enterprises; Small And Medium Enterprises (SMEs)
  • 4) By Industry: Pharmaceuticals; Biotech
  • Companies Mentioned: Veeva Systems Inc.; IQVIA Holdings Inc.; Salesforce.com Inc.; Oracle Corporation; SAP SE
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; pharma and biotech CRM software indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Pharma And Biotech CRM Software - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Pharma And Biotech CRM Software Market Definition And Segmentations
  • 6.4 Market Segmentation By Technology
    • 6.4.1 Artificial Intelligence Customer Relationship Management (CRM)
    • 6.4.2 Conventional Customer Relationship Management (CRM)
  • 6.5 Market Segmentation By Deployment
    • 6.5.1 On-Premises
    • 6.5.2 Cloud-Based
  • 6.6 Market Segmentation By Enterprise Size
    • 6.6.1 Large Enterprises
    • 6.6.2 Small And Medium Enterprises (SMEs)
  • 6.7 Market Segmentation By Industry
    • 6.7.1 Pharmaceuticals
    • 6.7.2 Biotech

7 Major Market Trends

  • 7.1 Integrating Electronic Health Records Into Pharma CRM Systems
  • 7.2 Strategic Partnerships Driving Innovation In Pharma And Biotech CRM Software
  • 7.3 Voice-Controlled CRM Interfaces Boosting Productivity In Pharma Sales

8 Global Pharma And Biotech CRM Software Growth Analysis And Strategic Analysis Framework

  • 8.1 Global: PESTEL Analysis
    • 8.1.1 Political
    • 8.1.2 Economic
    • 8.1.3 Social
    • 8.1.4 Technological
    • 8.1.5 Environmental
    • 8.1.6 Legal
  • 8.2 End Users of B2B Market
    • 8.2.1 Pharmaceutical Companies
    • 8.2.2 Biotechnology Companies
  • 8.3 Global Market Size and Growth
  • 8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
    • 8.4.1 Market Drivers 2019 - 2024
    • 8.4.2 Market Restraints 2019 - 2024
  • 8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
  • 8.6 Forecast Growth Contributors/Factors
    • 8.6.1 Quantitative Growth Contributors
    • 8.6.2 Drivers
    • 8.6.3 Restraints
  • 8.7 Global Pharma And Biotech CRM Software Total Addressable Market (TAM)

9 Global Pharma And Biotech CRM Software Market Segmentation

  • 9.1 Global Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.2 Global Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.3 Global Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.4 Global Pharma And Biotech CRM Software Market, Segmentation By Industry, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.5 Global Pharma And Biotech CRM Software Market, Sub-Segmentation Of Artificial Intelligence Customer Relationship Management (CRM), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, Value ($ Million)
  • 9.6 Global Pharma And Biotech CRM Software Market, Sub-Segmentation Of Conventional Customer Relationship Management (CRM), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, Value ($ Million)

10 Pharma And Biotech CRM Software Market, Regional and Country Analysis

  • 10.1 Global Pharma And Biotech CRM Software Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.2 Global Pharma And Biotech CRM Software Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

  • 11.1 Summary
  • 11.2 Market Overview
    • 11.2.1 Region Information
    • 11.2.2 Market Information
    • 11.2.3 Background Information
    • 11.2.4 Government Initiatives
    • 11.2.5 Regulations
    • 11.2.6 Regulatory Bodies
    • 11.2.7 Major Associations
    • 11.2.8 Taxes Levied
    • 11.2.9 Corporate Tax Structure
    • 11.2.10 Investments
    • 11.2.11 Major Companies
  • 11.3 Asia Pacific Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.4 Asia Pacific Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.5 Asia Pacific Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.6 Asia-Pacific Pharma And Biotech CRM Software Market: Country Analysis
  • 11.7 China Market
  • 11.8 Summary
  • 11.9 Market Overview
    • 11.9.1 Country Information
    • 11.9.2 Market Information
    • 11.9.3 Background Information
    • 11.9.4 Government Initiatives
    • 11.9.5 Regulations
    • 11.9.6 Regulatory Bodies
    • 11.9.7 Major Associations
    • 11.9.8 Taxes Levied
    • 11.9.9 Corporate Tax Structure
    • 11.9.10 Investments
    • 11.9.11 Major Companies
  • 11.10 China Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.11 China Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.12 China Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.13 India Market
  • 11.14 India Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.15 India Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.16 India Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.17 Japan Market
  • 11.18 Summary
  • 11.19 Market Overview
    • 11.19.1 Country Information
    • 11.19.2 Market Information
    • 11.19.3 Background Information
    • 11.19.4 Government Initiatives
    • 11.19.5 Regulations
    • 11.19.6 Regulatory Bodies
    • 11.19.7 Major Associations
    • 11.19.8 Taxes Levied
    • 11.19.9 Corporate Tax Structure
    • 11.19.10 Investments
    • 11.19.11 Major Companies
  • 11.20 Japan Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.21 Japan Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.22 Japan Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.23 Australia Market
  • 11.24 Australia Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.25 Australia Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.26 Australia Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.27 Indonesia Market
  • 11.28 Indonesia Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.29 Indonesia Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.30 Indonesia Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.31 South Korea Market
  • 11.32 Summary
  • 11.33 Market Overview
    • 11.33.1 Country Information
    • 11.33.2 Market Information
    • 11.33.3 Background Information
    • 11.33.4 Government Initiatives
    • 11.33.5 Regulations
    • 11.33.6 Regulatory Bodies
    • 11.33.7 Major Associations
    • 11.33.8 Taxes Levied
    • 11.33.9 Corporate Tax Structure
    • 11.33.10 Investments
    • 11.33.11 Major Companies
  • 11.34 South Korea Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.35 South Korea Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.36 South Korea Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate tax structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Western Europe Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.4 Western Europe Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.5 Western Europe Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.6 Western Europe Pharma And Biotech CRM Software Market: Country Analysis
  • 12.7 UK Market
  • 12.8 UK Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.9 UK Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.10 UK Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.11 Germany Market
  • 12.12 Germany Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.13 Germany Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.14 Germany Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.15 France Market
  • 12.16 France Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.17 France Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.18 France Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.19 Italy Market
  • 12.20 Italy Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.21 Italy Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.22 Italy Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.23 Spain Market
  • 12.24 Spain Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.25 Spain Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.26 Spain Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Major companies
  • 13.3 Eastern Europe Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.4 Eastern Europe Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.5 Eastern Europe Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.6 Eastern Europe Pharma And Biotech CRM Software Market: Country Analysis
  • 13.7 Russia Market
  • 13.8 Russia Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.9 Russia Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.10 Russia Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Investments
    • 14.2.11 Major Companies
  • 14.3 North America Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.4 North America Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.5 North America Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.6 North America Pharma And Biotech CRM Software Market: Country Analysis
  • 14.7 USA Market
  • 14.8 Summary
  • 14.9 Market Overview
    • 14.9.1 Country Information
    • 14.9.2 Market Information
    • 14.9.3 Background Information
    • 14.9.4 Government Initiatives
    • 14.9.5 Regulations
    • 14.9.6 Regulatory Bodies
    • 14.9.7 Major Associations
    • 14.9.8 Taxes Levied
    • 14.9.9 Corporate Tax Structure
    • 14.9.10 Investments
    • 14.9.11 Major Companies
  • 14.10 USA Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.11 USA Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.12 USA Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.13 Canada Market
  • 14.14 Summary
  • 14.15 Market Overview
    • 14.15.1 Region Information
    • 14.15.2 Market Information
    • 14.15.3 Background Information
    • 14.15.4 Government Initiatives
    • 14.15.5 Regulations
    • 14.15.6 Regulatory Bodies
    • 14.15.7 Major Associations
    • 14.15.8 Taxes Levied
    • 14.15.9 Corporate Tax Structure
    • 14.15.10 Investments
    • 14.15.11 Major Companies
  • 14.16 Canada Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.17 Canada Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.18 Canada Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Major Companies
  • 15.3 South America Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.4 South America Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.5 South America Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.6 South America Pharma And Biotech CRM Software Market: Country Analysis
  • 15.7 Brazil Market
  • 15.8 Brazil Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.9 Brazil Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.10 Brazil Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Major Companies
  • 16.3 Middle East Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.4 Middle East Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.5 Middle East Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Major Companies
  • 17.3 Africa Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.4 Africa Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.5 Africa Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

  • 18.1 Company Profiles
  • 18.2 Veeva Systems Inc
    • 18.2.1 Company Overview
    • 18.2.2 Products And Services
    • 18.2.3 Business Strategy
    • 18.2.4 Financial Overview
  • 18.3 IQVIA Holdings Inc
    • 18.3.1 Company Overview
    • 18.3.2 Products And Services
    • 18.3.3 Business Strategy
    • 18.3.4 Financial Overview
  • 18.4 Salesforce Inc
    • 18.4.1 Company Overview
    • 18.4.2 Products And Services
    • 18.4.3 Business Strategy
    • 18.4.4 Financial Overview
  • 18.5 Oracle Corporation
    • 18.5.1 Company Overview
    • 18.5.2 Products And Services
    • 18.5.3 Business Strategy
    • 18.5.4 Financial Overview
  • 18.6 SAP SE
    • 18.6.1 Company Overview
    • 18.6.2 Products And Services
    • 18.6.3 Financial Overview

19 Other Major And Innovative Companies

  • 19.1 Microsoft Corporation
    • 19.1.1 Company Overview
    • 19.1.2 Products And Services
  • 19.2 Zoho Corporation Pvt. Ltd.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
  • 19.3 Pega Systems Inc.
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
  • 19.4 HubSpot Inc.
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
  • 19.5 Indegene Private Limited
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
  • 19.6 Aurea Software Inc.
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
  • 19.7 Axtria Inc.
    • 19.7.1 Company Overview
    • 19.7.2 Products And Services
  • 19.8 Pipedrive Inc.
    • 19.8.1 Company Overview
    • 19.8.2 Products And Services
  • 19.9 Syneos Health Inc.
    • 19.9.1 Company Overview
    • 19.9.2 Products And Services
  • 19.10 Close-Up International Limited
    • 19.10.1 Company Overview
    • 19.10.2 Products And Services
  • 19.11 CRMNEXT Pharmaceutical
    • 19.11.1 Company Overview
    • 19.11.2 Products And Services
  • 19.12 SugarCRM Inc.
    • 19.12.1 Company Overview
    • 19.12.2 Products And Services
  • 19.13 Creatio (formerly bpm'online)
    • 19.13.1 Company Overview
    • 19.13.2 Products And Services
  • 19.14 StayinFront Inc.
    • 19.14.1 Company Overview
    • 19.14.2 Products And Services
  • 19.15 Synergistix Inc.
    • 19.15.1 Company Overview
    • 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Valsoft Acquired Exeevo
  • 22.2 Zensar Technologies Acquired BridgeView Life Sciences
  • 22.3 Nomadia Acquired Nomadvantage
  • 22.4 Aktana Acquired Tact.ai

23 Recent Developments In Pharma And Biotech CRM Software Market

  • 23.1 Expansion Of AI-Powered, Region-Specific CRM Solutions In Emerging Markets
  • 23.2 AI-Powered Healthcare Assistant Streamlines Clinical Workflows

24 Opportunities And Strategies

  • 24.1 Global Pharma And Biotech CRM Software Market In 2029 - Countries Offering Most New Opportunities
  • 24.2 Global Pharma And Biotech CRM Software Market In 2029 - Segments Offering Most New Opportunities
  • 24.3 Global Pharma And Biotech CRM Software Market In 2029 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Pharma And Biotech CRM Software Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer